Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era

AD Wagner, M Moehler - Current opinion in oncology, 2009 - journals.lww.com
Adequately powered, randomized phase III trials are necessary to define the clinical role of
targeted therapies in advanced gastric cancer. Biomarker studies to correlate with treatment …
被引用次数：98 相关文章

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

AD Wagner, M Moehler - Current opinion in oncology, 2009 - folia.unifr.ch
Adequately powered, randomized phase III trials are necessary to define the clinical role of
targeted therapies in advanced gastric cancer. Biomarker studies to correlate with treatment …

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

AD Wagner, M Moehler - Current Opinion in Oncology, 2009 - europepmc.org
Adequately powered, randomized phase III trials are necessary to define the clinical role of
targeted therapies in advanced gastric cancer. Biomarker studies to correlate with treatment …

[引用][C] Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era

AD Wagner, M Moehler - Current Opinion in Oncology, 2009 - cir.nii.ac.jp
Development of targeted therapies in advanced gastric cancer: promising exploratory steps
in a new era | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era

AD Wagner, M Moehler - Current opinion in oncology, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose of review Many chemotherapeutic drugs, including fluoropyrimidines, platinums,
CPT-11, taxanes and adriamycin have single-agent activity in advanced gastric cancer …

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

AD Wagner, M Moehler - Current opinion in oncology, 2009 - sonar.ch
Adequately powered, randomized phase III trials are necessary to define the clinical role of
targeted therapies in advanced gastric cancer. Biomarker studies to correlate with treatment …